Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Estudio para obtener información sobre los medicamentos del estudio llamados nirmatrelvir/ritonavir en personas inmunodeprimidas de al menos 12 años de edad con la COVID-19
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: PAXLOVID
Language: Spanish
ViewDownloadPrint
A Study to Learn About a Repeat 5-Day Treatment With Nirmatrelvir/Ritonavir in People With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
Category & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 2
Medicine: PAXLOVID
Language: English
ViewDownloadPrint
Study of Oral Nirmatrelvir (PF-07321332)/Ritonavir Compared With Placebo in Nonhospitalized Adults Who are at Higher Risk of Severe COVID-19 Illness
Category & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 2/3
Medicine: PAXLOVID
Language: English
ViewDownloadPrint
A Study of 2 Treatment Plans of Nirmatrelvir With Ritonavir Compared to Placebo in Preventing COVID-19 Among Adults Who Lived in the Same House With a Person Who Had COVID-19
Category & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 2/3
Medicine: PAXLOVID
Language: English
ViewDownloadPrint
A Study to Learn If Nirmatrelvir (PF-07321332)/ Ritonavir Were Effective and Safe Compared With Placebo in Nonhospitalized Adults With COVID-19 Who Have Low or Standard Risk of Worsening to a Severe Illness
Category & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 2/3
Medicine: PAXLOVID
Language: English
ViewDownloadPrint
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-04518600, PF-05082566
Language: English
ViewDownloadPrint
A Study to Learn if TBE Vaccine was Safe in Healthy Japanese People 1 Year of Age and Older, and if TBE Vaccine Produced an Immune Response Against a Germ called Tick-Borne Encephalitis Virus
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06830414
Language: English
ViewDownloadPrint
A Study of Fosmanogepix in Participants With Invasive Mold Infections
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Fosmanogepix (PF-07842805)
Language: English
ViewDownloadPrint
A Study to Investigate the Safety, and Tolerability, of Topically Administered PF- 07295324 and PF-07259955, in Healthy Adults
Category & Conditions: Skin Diseases and Conditions
Study Phase : 1
Medicine: PF-07259955, PF-07295324
Language: English
ViewDownloadPrint
A study to assess the efficacy and safety of ceftazidime-avibactam plus metronidazole in Japanese patients with complicated intraabdominal infections.
Category & Conditions: Infections and Infectious Diseases
Study Phase : 3
Medicine: Ceftazidime-Avibactam
Language: English
ViewDownloadPrint
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-07263689
Language: English
ViewDownloadPrint
A Study to Look at the Safety and the Immune Response to Candidates Against Pneumococcus Bacteria
Category & Conditions: Vaccine-related Conditions
Study Phase : 1
Medicine: PF-07831695
Language: English
ViewDownloadPrint